Ling‐Wen Ding

6.2k citations

65 papers · 2.4k · 1 hit paper · h-index 29

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
Geriatrics and Gerontology top 5%

Papers in

Molecular Biology 46
- Cancer-related gene regulation 8
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 7
- Ubiquitin and proteasome pathways 7
- Protein Degradation and Inhibitors 4
Cancer Research 15
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 5

Co-authors: H. Phillip Koeffler (37 shared papers)De‐Chen Lin (18 shared papers)Boon Cher Goh (7 shared papers)Anand Mayakonda (12 shared papers)Qiao‐Yang Sun (19 shared papers)Xiaoqiang Xiang (4 shared papers)Lingzhi Wang (5 shared papers)Paul C. Ho (2 shared papers)
Journals: Cancer Research (10 papers)Oncogene (5 papers)Advanced Materials (4 papers)Blood (3 papers)British Journal of Cancer (3 papers)
Partner nations: Singapore China United States

In The Last Decade

Ling‐Wen Ding

60 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Resveratrol for cancer therapy: Challenges and future perspectives 2021 · 334 citations

Peers

Countries citing papers authored by Ling‐Wen Ding

Since Specialization

Citations

This map shows the geographic impact of Ling‐Wen Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Wen Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Wen Ding more than expected).

Fields of papers citing papers by Ling‐Wen Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Wen Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Wen Ding. The network helps show where Ling‐Wen Ding may publish in the future.

Co-authors

The 25 scholars most cited alongside Ling‐Wen Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ling‐Wen Ding Line = papers co-authored together Ling‐Wen Ding links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Resveratrol for cancer therapy: Challenges and future perspectives Cancer Letters ·Boxu Ren, Marabeth Xin-Yi Kwah, Cuiliu Liu, Zhaowu Ma, Muthu K. Shanmugam, Ling‐Wen Ding, Xiaoqiang Xiang, Paul C. Ho, Lingzhi Wang, Pei Shi Ong, Boon Cher Goh Hit paper breakdown →	2021	334
2	Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma Gut ·Yan-Yi Jiang, De‐Chen Lin, Anand Mayakonda, Masaharu Hazawa, Ling‐Wen Ding, Wen-Wen Chien, Liang Xu, Ye Chen, Jin‐Fen Xiao, William Senapedis, Erkan Baloglu, Deepika Kanojia, Shang Li, Xin Xu, Henry Yang, Jeffrey Tyner, Ming‐Rong Wang, H. Phillip Koeffler	2016	168
3	Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma Cancer Research ·De‐Chen Lin, Anand Mayakonda, Huy Q. Dinh, Pinbo Huang, Lehang Lin, Xiaoping Liu, Ling‐Wen Ding, Jie Wang, Benjamin P. Berman, Erwei Song, Dong Yin, H. Phillip Koeffler	2017	148
4	Celastrol in cancer therapy: Recent developments, challenges and prospects Cancer Letters ·Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang, Arul Goel, Ling‐Wen Ding, Andrea Li‐Ann Wong, Paul C. Ho, Gautam Sethi, Xiaoqiang Xiang, Boon Cher Goh	2021	92
5	Ultrathin Clay Nanoparticles‐Mediated Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy Advanced Materials ·Jianping Liu, Jiezhao Zhan, Ye Zhang, Lin Huang, H. J. Yang, Jie Feng, Ling‐Wen Ding, Zheyu Shen, Xiaoyuan Chen	2023	88
6	Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas Gut ·De‐Chen Lin, Huy Q. Dinh, Jian‐Jun Xie, Anand Mayakonda, Tiago C. Silva, Yan‐Yi Jiang, Ling‐Wen Ding, Jianzhong He, Xiu‐E Xu, Jia‐Jie Hao, Ming‐Rong Wang, Chunquan Li, Li‐Yan Xu, En‐Min Li, Benjamin P. Berman, H. Phillip Koeffler	2017	84
7	ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma Oncogene ·Masaharu Hazawa, D-C Lin, Harish K. Handral, Liang Xu, Yinglu Chen, Jiang Yy, Anand Mayakonda, Ling‐Wen Ding, Xianbin Meng, Arjun Sharma, Sokol Ethan Samuel, Mohammad Mehdi Movahednia, Richard W. Wong, Henry Yang, Tong Cao, H. Phillip Koeffler	2016	82
8	Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma Cancer Research ·Yuan Jiang, Yan-Yi Jiang, Anand Mayakonda, Moli Huang, Ling‐Wen Ding, Lin Han, Fenggang Yu, Yanan Lu, Thomas Kwok Seng Loh, M Chow, Samantha L. Savage, Jeffrey Tyner, De‐Chen Lin, H. Phillip Koeffler	2017	77
9	Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells Oncotarget ·Wenwen Chien, Ling‐Wen Ding, Qiao‐Yang Sun, Lucia Torres Fernández, Kar-Tong Tan, Jin-Fen Xiao, Su Lin Lim, Manoj Garg, Kian Leong Lee, Shojiro Kitajima, Sumiko Takao, Wei Zhong Leong, Haibo Sun, Itay Tokatly, Lorenz Poellinger, Sigal Gery, Phillip H. Koeffler	2014	71
10	An Integrated Polymeric mRNA Vaccine without Inflammation Side Effects for Cellular Immunity Mediated Cancer Therapy Advanced Materials ·Pei Huang, Lingsheng Jiang, Hui Pan, Ling‐Wen Ding, Bo Zhou, Mengyao Zhao, Jianhua Zou, Benhao Li, Meiwei Qi, Hongzhang Deng, Yongfeng Zhou, Xiaoyuan Chen	2022	68
11	Laminin-5γ-2 (LAMC2) Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Progression, Migration, and Invasion by Modulating Signaling of EGFR The Journal of Clinical Endocrinology & Metabolism ·Manoj Garg, Deepika Kanojia, Ryoko Okamoto, Saket Jain, Vikas Madan, Wenwen Chien, Abhishek Sampath Kumar, Ling‐Wen Ding, Meng Xuan, Jonathan Said, Ngan Doan, Lizhen Liu, Henry Yang, Sigal Gery, Glenn D. Braunstein, H. Phillip Koeffler	2013	64
12	SOX7 is down-regulated in lung cancer Journal of Experimental & Clinical Cancer Research ·Takahide Hayano, Manoj Garg, Dong Yin, Makoto Sudo, Norihiko Kawamata, Shuo Shi, Wenwen Chien, Ling‐Wen Ding, Geraldine Leong, Seiichi Mori, Dong Xie, Patrick Tan, H. Phillip Koeffler	2013	61
13	A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma Cancer Research ·Sai Ma, Bo Zhou, Qian Yang, Yunzhi Pan, Wei Yang, Stephen J. Freedland, Ling‐Wen Ding, Michael R. Freeman, Joshua J. Breunig, Neil A. Bhowmick, Jian Pan, H. Phillip Koeffler, De‐Chen Lin	2021	60
14	Using silica particles to isolate total RNA from plant tissues recalcitrant to extraction in guanidine thiocyanate Analytical Biochemistry ·Ling‐Wen Ding, Qiao‐Yang Sun, Zhaoyu Wang, Yong-Bin Sun, Zeng‐Fu Xu	2007	60
15	Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer Molecular Oncology ·Wenwen Chien, Qiao‐Yang Sun, Kian Leong Lee, Ling‐Wen Ding, Peer Wuensche, Lucia Torres Fernández, Kar-Tong Tan, Itay Tokatly, Norazean Zaiden, Lorenz Poellinger, Seiichi Mori, Henry Yang, Jeffrey Tyner, H. Phillip Koeffler	2015	57
16	Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells Biomedicine & Pharmacotherapy ·Hélène Marijon, Der‐Horng Lee, Ling‐Wen Ding, Haibo Sun, Sigal Gery, Aimery de Gramont, H. Phillip Koeffler	2018	55
17	KPT-330 has antitumour activity against non-small cell lung cancer British Journal of Cancer ·Haibo Sun, Norimichi Hattori, Wenwen Chien, Qiao‐Yang Sun, Makoto Sudo, G L E-Ling, Ling‐Wen Ding, Su Lin Lim, Sharon Shacham, Michael Kauffman, Tsuyoshi Nakamaki, H. Phillip Koeffler	2014	53
18	Genomic and Functional Analysis of the E3 Ligase PARK2 in Glioma Cancer Research ·De‐Chen Lin, Liang Xu, Ye Chen, Haiyan Yan, Masaharu Hazawa, Ngan Doan, Jonathan Said, Ling‐Wen Ding, Lizhen Liu, Henry Yang, Shizhu Yu, Michael Kahn, Dong Yin, H. Phillip Koeffler	2015	51
19	EXPRESSION OF CONCERN: Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo Molecular Carcinogenesis ·Wenwen Chien, Der‐Horng Lee, Yun Zheng, Peer Wuensche, Rosie Alvarez, Ling‐Wen Ding, Ahmed Aribi, Su Ming Thean, Ngan Doan, Jonathan Said, H. Phillip Koeffler	2013	47
20	Extracellular vesicles, the cornerstone of next-generation cancer diagnosis? Seminars in Cancer Biology ·Jiayi Weng, Xiaoqiang Xiang, Ling‐Wen Ding, Andrea Li‐Ann Wong, Qi Zeng, Gautam Sethi, Lingzhi Wang, Soo Chin Lee, Boon Cher Goh	2021	46

About Ling‐Wen Ding

Ling‐Wen Ding is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 65 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer-related gene regulation (8 papers), RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related molecular mechanisms research (7 papers), Ubiquitin and proteasome pathways (7 papers), interferon and immune responses (6 papers), MicroRNA in disease regulation (5 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Cancer Research (541 citations), Geriatrics and Gerontology (105 citations), Molecular Biology (1.6k citations), Oncology (506 citations) and Immunology (260 citations). Ling‐Wen Ding has collaborated with scholars based in Singapore, China and United States. Frequent co-authors include H. Phillip Koeffler, De‐Chen Lin, Boon Cher Goh, Anand Mayakonda, Qiao‐Yang Sun, Xiaoqiang Xiang, Lingzhi Wang, Paul C. Ho, Wenwen Chien and Pei Shi Ong. Their work appears in journals such as Cancer Research, Oncogene, Advanced Materials, Blood and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ling‐Wen Ding

Impact in

Papers in i

In The Last Decade

Ling‐Wen Ding

Hit Papers

Peers

Countries citing papers authored by Ling‐Wen Ding

Fields of papers citing papers by Ling‐Wen Ding

All Works

About Ling‐Wen Ding

Explore authors with similar magnitude of impact

Papers in